Switzerland
  • Switzerland
  • USA
  • confinis ag, Allee 1B, CH-6210 Sursee, Switzerland
  • info.ch@confinis.com
  • +41 26 494 8 494
  • confinis corp., 4445 Willard Ave, Suite 600, Chevy Chase, MD 20815, USA
  • info.usa@confinis.com
  • +1 240 252 0891
confinis
confinis
  • Home
  • About
  • Services
    • Combination Products
    • In-Vitro Diagnostics
    • Product Development
    • QM, Auditing & Training
    • Regulatory Affairs
  • Blog
  • Join
    • Careers
    • Independent professional
  • Contact
    • Offices
    • Newsletter
    • Disclaimer
    • Cookie Policy
   
  • UK Responsible Person Services
    December 20, 2021
  • Join our second Start-up Workshop 2021!
    October 25, 2021
  • confinis launches new UK Responsible Person service in UK
    October 11, 2021
  • ISO/FDIS 11608 series opened for voting
    October 8, 2021
  • confinis partners with Irdeto to launch the first cybersecurity assessment tool in the medical devices industry
    July 6, 2021
  • confinis offers Swiss Representative Service
    June 18, 2021
  • Exporting Swiss Medical Devices to the EU
    May 26, 2021
  • Join our Startup Workshop 2021!
    April 24, 2021
  • … and Report your Post-Market Clinical Follow-up Evaluation!
    April 23, 2021
  • How to plan your post-market clinical follow up…
    March 10, 2021
  • 1
  • 2
  • 3
The confinis Blog

Welcome to the confinis blog. This is the place where we are writing about news, events and helpful information. Enjoy.

Archives
Categories
  • Conferences
  • confinis
  • Regulations
  • Workshops
Tags
#2017/745 #CHREP #FDA #machinelearning 2018 auto-injectors autoinjectors clinicalevaluation combination products confinis digitalhealth electromagneticcompatibility howto InstA ISO/TC84 ISO11608 ISO13485 IVD ivdr MDCG mdr mdr article 117 MedDO medicaldevices medicalsoftware medizinprodukte Medizinprodukteverordnung MepV MRA NIS on-body-delivery-systems pen-injectors peter studer PMS post-market-clinical-follow-up post-market-surveillance presentation qms regulations samd startup swiss-medtech switzerland TOPRA ukrp

Combination Products Services

  • MDR Article 117
  • Combination Products
  • Design Control
  • Risk Management
  • Usability Engineering
  • Clinical Evaluation
  • 21 CFR Part 4

In-Vitro Diagnostics

  • New IVDR
  • Classification and Regulatory Strategy
  • CE marking, FDA and global product registrations
  • Performance Evaluation
  • Software

Product Development Services

  • Digital Health
  • Design Control
  • Risk Management
  • Usability Engineering
  • Clinical Evaluation
  • Regulatory Due Diligence
  • Combination Products
  • DHF Remediation
  • Software Validation
  • Mobile Medical Apps
  • Production & Process Optimization
  • Packaging

QM, Auditing & Training Services

  • eQMS
  • Quality Management System
  • Design Control
  • Training
  • Auditing
  • Validation / Qualification
  • FDA Inspections
  • Postmarket Surveillance

Regulatory Affairs & Market Authorization

  • Digital Health
  • Regulatory Affairs Strategy
  • Market Authorization in Europe
  • Market Authorization in the USA
  • Market Authorization in other Markets
  • EC Representative
  • US Agent
RAPS - Enterprise Member Logo
© 2022 confinis ag. All rights reserved. Disclaimer & Cookie Policy. Website: SENF Digital Graphics: zwo13